SRNE
Sorrento Therapeutics, Inc.
SRNE
SRNE
Delisted
SRNE was delisted on the 22nd of February, 2023.
83 hedge funds and large institutions have $75.2M invested in Sorrento Therapeutics, Inc. in 2019 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 34 increasing their positions, 17 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
31% less capital invested
Capital invested by funds: $108M → $75.2M (-$33.2M)
Holders
83
Holding in Top 10
1
Calls
$1.57M
Puts
$1.15M
Top Buyers
| 1 | +$5.58M | |
| 2 | +$3.74M | |
| 3 | +$1.77M | |
| 4 |
Nuveen Asset Management
Chicago,
Illinois
|
+$1.2M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.06M |
Top Sellers
| 1 | -$324K | |
| 2 | -$260K | |
| 3 | -$247K | |
| 4 |
Morgan Stanley
New York
|
-$246K |
| 5 |
PP
Paloma Partners
Greenwich,
Connecticut
|
-$182K |